eu opioid drugs market

EU Opioid Drugs Market, Market Segmented by Product type (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, and Others), and by Application (Pain Relief, Anaesthesia, Cough Suppression, Diarrhoea Suppression, Deaddiction)- Growth, Trends and Forecast, 2019-2028

  • Published Date: 2022-12-26
  • Report ID: 138211
  • Pages: 200
  • Format: prudent report format

Report Overview

The EU Opioid Drugs Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 2.45% during the forecast period

Opioidsare substances that work in the nervous system of the body or in specific receptors in the brain to reduce the intensity of pain. Overdose deaths involvingopioids, including prescriptionopioids, heroin, and syntheticopioids(like fentanyl), have increased over six times



Market Drivers

The ongoing education programs and a surge in government initiatives regarding opioid usage are the major factors deciding the effective growth of the market. High demand of opioid drugs due to high prevalence of chronic pain and cancer patients and growing aging population demanding for pain therapeutics are also boosting the market


1. EU Opioid Drugs Market Overview
A. Market Size
2. EU Opioid Drugs Market Growth Drivers.
A. The ongoing education programs and a surge in government initiatives regarding opioid usage
B. High demand of opioid drugs due to high prevalence of chronic pain and cancer patients and growing aging population
3. EU Opioid Drugs Market Segmentation
A. By Products
I. Buprenorphine
II. Fentanyl
III. Hydrocodone
IV. Morphine
V. Oxycodone
VI. Tramadol
VII. Others
B. By Application
I. Pain Relief
II. Anaesthesia, Cough Suppression
III. Diarrhoea Suppression
IV. Deaddiction
4. EU Opioid Drugs Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Allergan Plc, Company overview, Product & Services, Strategies & Financials
B. Johnson & Johnson, Company overview, Product & Services, Strategies & Financials
C. Sanofi Aventis, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.